Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Zetia

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zetia was produced by Merck & Co. and Bayer.

FDA scrutiny of alirocumab hits Regeneron and Sanofi

FDA scrutiny of alirocumab hits Regeneron and Sanofi Alirocumab (also known as REGN727) has shown very positive activity in phase III trials reported to date, outperforming rival drug Zetia (ezetimibe) from Merck &Co as a monotherapy.

Amgen cholesterol antibody scores in another phase III trial

Amgen cholesterol antibody scores in another phase III trial effects. In these people alternative therapies, such as Merck's Zetia (ezetimibe), are used to try to meet treatment goals, and Amgen is banking on evolocumab taking a leadership position among ... And last month the company reported that the antibody

Amgen throws its hat into the cholesterol antibody ring

Amgen throws its hat into the cholesterol antibody ring The reductions seen with the drug were better than those achieved with either placebo or Merck &Co's Zetia (ezetimibe), and consistent with the results seen in phase II trials, said

Sanofi and Regeneron's cholesterol antibody aces phase III trial

Sanofi and Regeneron's cholesterol antibody aces phase III trial comparator drug Zetia (ezetimibe) from Merck &Co.

Merck profit slides as generics continue to bite

Merck profit slides as generics continue to bite HIV drug Isentress (raltegravir) climbed 5 per cent to $410m, holding up fairly well despite increased competition from the likes of Gilead Sciences' elvitegravir, while sales of cholesterol drugs Zetia (ezetimibe) ... and Vytorin (ezetimibe and

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics